jcm-logo

Journal Browser

Journal Browser

Selected Papers from the 4th International Conference on Inflammation and Infection Imaging

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nuclear Medicine & Radiology".

Deadline for manuscript submissions: closed (30 June 2025) | Viewed by 1214

Special Issue Editors


E-Mail Website
Guest Editor
Department of Surgical-Medical Sciences and Translational Medicine, University of Rome “Sapienza”, Rome, Italy
Interests: nuclear medicine; infection imaging; inflammation imaging; thyroid cancer imaging; pre-clinical imaging; imaging immuno-therapy; imaging autoimmune diseases
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Department of Medical-Surgical Sciences and Translational Medicine, University Hospital S. Andrea, “Sapienza” University of Rome, Rome, Italy
Interests: inflammation imaging; tumor micro-environment; personalized medicine

E-Mail
Guest Editor
Department of Medical-Surgical Sciences and Translational Medicine, University Hospital S. Andrea, “Sapienza” University of Rome, Rome, Italy
Interests: radiochemistry; nanotechnologies; nanoparticles; bacteria imaging

Special Issue Information

Dear Colleagues,

Following a tradition started in 1993, the 4th edition of the International Congress on "Imaging infections and inflammation" has been organized in Roma (Italy) from 5 to 7 December, 2024.

Scientific sessions included cardiovascular infections, bone infections, sterile inflammatory diseases, tumor microenvironments, and radiolabeled probes for imaging bacteria and fungi.

Each session included several lectures and roundtable discussions with the participation of several scientists and clinicians, experts in the field.

The best three oral presentations were given awards.

Since the high clinical relevance of such congress and the number and quality of studies presented, we decided to launch a Special Issue of the Journal of Clinical Medicine that could include all abstracts of congress presentations and a few selected full papers, accepted after peer review.

The early diagnosis of occult infections is a very important issue in medicine, especially for infections that do not present with obvious clinical signs but can have serious consequences if not treated promptly. The use of imaging techniques to detect hidden infections is becoming increasingly important due to their ability to visualize areas of the body that are difficult to explore, often before serious symptoms develop.

In addition to computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, nuclear medicine techniques have improved enormously in the last decade thanks to the availability of several new radiopharmaceuticals for single-photon emission computed tomography (SPECT) and positron emission tomography (PET) use.

Rapid identification of occult infections will allow starting targeted and personalized treatment, reducing the risk of complications.

Furthermore, early diagnosis of infection in the early stages will contribute to reducing the costs of patients’ treatment with better prognoses, especially in immunocompromised patients or those with comorbidities.

One of the major challenges is the differential diagnosis between sterile inflammation and septic infection. Despite the use of radiolabeled autologous white blood cells that can allow us to differentiate inflammation from infection, the gold standard technique would be to directly image and quantify the presence of bacteria or fungi.

Another important field of application of nuclear medicine techniques is the study of tumor microenvironments. Here, by using radiopharmaceuticals that specifically target fibroblasts, lymphocytes, endothelial, or mesenchymal cells, the aim is to establish a non-invasive tool for prognostic purposes and for selecting tailored treatment.

Both fields have an enormous clinical and economic impact and will drive nuclear medicine research for the next decades.

Prof. Dr. Alberto Signore
Dr. Chiara Lauri
Dr. Michela Varani
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • infection imaging
  • inflammation imaging
  • imaging tumor micro-environment
  • bacteria imaging
  • new radiopharmaceuticals

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

15 pages, 1576 KiB  
Article
A Head-to-Head Comparison Between [18F]Fluorodeoxyglucose ([18F]FDG) Positron Emission Tomography/Computed Tomography (PET/CT) and 99mTechnetium-Hexamethylpropylene Amine Oxime (HMPAO)-Labeled Leukocyte Scintigraphy in a Case Series of Patients with Suspected Vascular Prosthesis Infection: To Trust Is Good, but to Check Is Better
by Marina Scarpuzza, Alice Ambrogio, Andrea Leo, Lorenzo Roberto Suardi, Michele Marconi, Marco Falcone, Raffaella Berchiolli and Elena Lazzeri
J. Clin. Med. 2025, 14(12), 4352; https://doi.org/10.3390/jcm14124352 - 18 Jun 2025
Viewed by 428
Abstract
Background: Prosthetic vascular graft infection (PVGI) is a serious complication associated with vascular prostheses. Nuclear medicine techniques, including [18F]fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and 99mtechnetium-hexamethylpropylene amine oxime (HMPAO)-labeled leukocyte (WBC) scintigraphy, are part of the MAGIC diagnostic criteria for [...] Read more.
Background: Prosthetic vascular graft infection (PVGI) is a serious complication associated with vascular prostheses. Nuclear medicine techniques, including [18F]fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and 99mtechnetium-hexamethylpropylene amine oxime (HMPAO)-labeled leukocyte (WBC) scintigraphy, are part of the MAGIC diagnostic criteria for PVGI. Methods: In this retrospective study, we analyzed eight patients with suspected PVGI who underwent both [18F]FDG PET/CT and WBC scintigraphy within an average of 8 days. Results: Of all eight patients (median age 69 years), three showed concordant positive results with both PET/CT and WBC, and their final diagnosis confirmed the presence of infection; five showed discordant results: in all five of these patients, PET/CT showed false-positive findings, whereas WBC correctly identified five true-negative cases. Conclusions: [18F]FDG PET/CT is highly sensitive but prone to false positives. WBC scintigraphy, combined with SPECT/CT, particularly in the evaluation of the treatment response, showed greater specificity, and it may warrant consideration as a MAGIC major diagnostic criterion for PVGI. Full article
Show Figures

Figure 1

14 pages, 4450 KiB  
Article
Somatostatin Receptor Scintigraphy in Autoimmune Syndrome Induced by Silicone Breast Implants: Pre- and Postexplantation Findings
by Luz Kelly Anzola, Sara Ramirez, Sergio Moreno, Camilo Vargas, Sebastian Rojas and José Nelson Rivera
J. Clin. Med. 2025, 14(12), 4141; https://doi.org/10.3390/jcm14124141 - 11 Jun 2025
Viewed by 395
Abstract
Background: Silicone breast implants have been linked to autoimmune/inflammatory syndrome induced by adjuvants (ASIA). This study evaluates the role of 99mTc-HYNIC-TOC somatostatin receptor scintigraphy in assessing somatostatin-mediated inflammation and the impact of explantation on inflammatory activity. Methods: Fifty patients with silicone breast [...] Read more.
Background: Silicone breast implants have been linked to autoimmune/inflammatory syndrome induced by adjuvants (ASIA). This study evaluates the role of 99mTc-HYNIC-TOC somatostatin receptor scintigraphy in assessing somatostatin-mediated inflammation and the impact of explantation on inflammatory activity. Methods: Fifty patients with silicone breast implants and symptoms suggestive of ASIA were evaluated. Pre- and postexplantation imaging was performed using 99mTc-HYNIC-TOC scintigraphy. Matthews correlation coefficients quantified associations between clinical symptoms and imaging findings, and autoantibody profiles were analysed. Results: Scintigraphy identified a significant uptake in organs associated with autoimmune symptoms, particularly joints and salivary glands. Strong correlations were found between imaging findings and symptoms, including knee pain (MCC = 0.81) and sicca syndrome (MCC = 0.96). Explantation resolved abnormal uptake in the surgical bed, though variable uptake persisted in other organs, reflecting systemic inflammatory heterogeneity. Autoantibody analysis revealed positivity in 66% of patients, with antinuclear antibodies being most frequent (30%). Conclusions: 99mTc-HYNIC-TOC scintigraphy effectively evaluates organ-specific inflammation in ASIA. Explantation reduces localized inflammation but does not consistently address systemic autoimmune responses. Larger prospective studies are needed to validate these findings and improve management strategies for ASIA. Full article
Show Figures

Figure 1

Review

Jump to: Research

11 pages, 251 KiB  
Review
PET and SPECT Imaging of Macrophages in the Tumor Stroma: An Update
by Shaobo Li, Alex Maes, Tijl Vermassen, Justine Maes, Chabi Sathekge, Sylvie Rottey and Christophe Van de Wiele
J. Clin. Med. 2025, 14(14), 5075; https://doi.org/10.3390/jcm14145075 - 17 Jul 2025
Viewed by 208
Abstract
Tumor-associated macrophages (TAMs) are pivotal immune cells within the tumor stroma, whose dynamic alterations significantly impact tumor progression and therapeutic responses. Conventional methods for TAM detection, such as biopsy, are invasive and incapable of whole-body dynamic monitoring. In contrast, positron emission tomography (PET) [...] Read more.
Tumor-associated macrophages (TAMs) are pivotal immune cells within the tumor stroma, whose dynamic alterations significantly impact tumor progression and therapeutic responses. Conventional methods for TAM detection, such as biopsy, are invasive and incapable of whole-body dynamic monitoring. In contrast, positron emission tomography (PET) and single-photon emission computed tomography (SPECT) offer a non-invasive imaging approach by targeting TAM-specific biomarkers like CD206, TSPO, and CCR2. This review comprehensively summarizes the advancements in TAM-targeted imaging probes, including cell surface markers, metabolic/functional markers, and multifunctional nanoprobe, while assessing their potential in tumor immune surveillance and tumor targeting therapeutic applications. While current probes, including 68Ga-NOTA-anti-CD206 and 64Cu-Macrin, have exhibited high specificity and theragnostic potential in preclinical and early clinical trials, challenges such as target heterogeneity, off-target effects, and clinical translation persist. Moving forward, the advancement of multi-target probes, optimization of pharmacokinetics, and incorporation of multimodal imaging technologies are anticipated to further enhance the impact of TAM-targeted imaging in precision medicine and tumor immunotherapy, fostering the refinement of personalized treatment strategies and improving patient outcomes. Full article
Back to TopTop